This IVF website was created to help women and couples with infertility who are either beginning IVF or just found out that having a baby might require more work than they had originally expected.
When I was first going through IVF, I had a difficult time understanding my doctor, treatments, brochures and most infertility websites that attempted to explain my options and details of the IVF journey. So I decided to put together a website that would provide women and couples with practical and useful IVF information in a way that is "easy to understand".
In addition, SimplyIVF.com offers advice on how to best combine Western and Eastern medicine treatments such as acupuncture for IVF and herbs so that you too can have the full opportunity to experience the miracle of having a baby.
All links found on my website were personally selected to help you achieve your dream of having a baby.
Fertility News From Medical News Today
Jan 06, 2009 10:00PM
Jan 06, 2009 01:00AM
Women undergoing in vitro fertilization (IVF) require progesterone medication to help support early pregnancy, but the intramuscular injections for some forms of this medication can be painful for patients. Formulations of progesterone medication which can be administered by subcutaneous injection or vaginal suppository may offer similar results with better patient tolerance.
Jan 05, 2009 03:00AM
Building Work Starts On The Largest IVF Facility In The NHS, UK
A £3.3m plan to reorganise Reproductive Medicine services in Leeds, bringing them together for the first time in a single purpose-designed facility which will improve care for fertility patients, is getting underway. Building work will begin in the first week in January on the scheme, which will allow the two current fertility services in Leeds to be centralised on the Seacroft Hospital site into one unit.
Jan 04, 2009 01:00AM
Schering-Plough Announces European Submission Of Fertility Medicine Corifollitropin Alfa
Schering-Plough Corp., (NYSE: SGP), a leading provider of fertility treatments, announced today that the European Medicines Agency (EMEA) has validated (accepted for review) its Marketing Authorization Application (MAA) for corifollitropin alfa, the company's experimental, sustained follicle stimulant (SFS). This application will follow the Centralized Procedure.
Copyright 2009 Medical News Today
This site should not substitute personal professional, legal or medical advice.
